Stocks
Charles River Laboratories International, Inc.CRL
NYSEHealthcareLife Sciences Tools & Services$155.46+1.83%
Provides outsourced research and drug development services to pharmaceutical, biotechnology, and academic institutions, including preclinical testing, laboratory services, and research models used in early-stage drug discovery. The company plays a key role in the pharmaceutical R&D supply chain, sup...
Market Cap: $7.7B52W Range: $91.86 – $228.88
Congressional Interest in Charles River Laboratories International, Inc. (CRL)
9 members of Congress have disclosed 38 trades in Charles River Laboratories International, Inc. (CRL), a Healthcare company. The buy/sell breakdown shows 20 purchases versus 18 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
38
Unique Politicians
9
Buys
20
Sells
18
Who in Congress Is Trading CRL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-05 | Rohit Khanna | buy | $1K – $15K |
| 2026-01-29 | Rohit Khanna | sell | $1K – $15K |